Kansas City, Kan- Marc Slotnick, diagnosed with chronic lymphocytic leukemia (CLL) in his early 60s, has been through numerous treatments, including clinical trials.
He moved back to Kansas City to help others through a support group he co-founded with Dr. Marc Hoffman.
The group, part of Turning Point, provides emotional support for CLL patients and their families.
Marc Slotnick, chronic lymphocytic leukemia (CLL) patient
- Marc shares his experience of surrendering to cancer and the importance of not keeping it bottled up.
- He shares his coaching background and how it translates to helping cancer patients.
- The importance of maintaining a positive attitude and finding meaning in overcoming challenges is emphasized.
Dr. Marc Hoffman, Medical Director of Lymphoma and Myeloma Program, The University of Kansas Cancer Center
- Dr. Hoffman discusses the therapeutic revolution in CLL treatment, moving from intravenous drugs to oral agents.
- He explains the exciting advancements in CLL treatment and the potential for new, more effective drugs.
Jill Von Fange, Program Manager, Turning Point: Community Resource of The University of Kansas Health System
- Jill Von Fange explains Turning Point's role in providing emotional support for individuals and their families impacted by serious or chronic illnesses.
- The flexibility of Turning Point's free programs, available both in-person and online, is highlighted.
